Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2025-12-31 @ 1:25 PM
Study NCT ID:
NCT05371028
Status:
COMPLETED
Last Update Posted:
2025-04-06
First Post:
2022-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-28
First Submit QC Date:
None
Study First Post Date:
2022-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-06
Last Update Post Date Type:
ACTUAL